Suppr超能文献

微粒体膜相关载脂蛋白B是大鼠肝细胞原代培养物中分泌型极低密度脂蛋白的直接前体。

Microsomal membrane-associated apoB is the direct precursor of secreted VLDL in primary cultures of rat hepatocytes.

作者信息

Hebbachi A M, Gibbons G F

机构信息

Oxford Lipid Metabolism Group, Metabolic Research Laboratory, Nuffield Department of Clinical Medicine, University of Oxford, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK.

出版信息

J Lipid Res. 2001 Oct;42(10):1609-17.

Abstract

Brefeldin A (BFA) added to primary cultures of rat hepatocytes, at a concentration of 0.2 microg/ml, prevented the assembly of newly synthesized apolipoprotein B (apoB) into mature, secretory VLDL but did not prevent the secretion of apoB as denser particles (HDL apoB), or of albumin. The unassembled apoB remained associated with the membranes of the cellular microsomal fraction. There was no effect of BFA on the removal of apoB from the lumen of these vesicles. VLDL apoB formed only a minor component of the total apoB in the microsomal lumen. Higher (5 microg/ml) concentrations of BFA were required to prevent the secretion of HDL apoB and albumin. Under these conditions apoB accumulated in the microsomal lumen, as well as in the membranes of these vesicles. Again, apoB VLDL formed only a minor proportion of the total lumenal apoB. ApoB-48 VLDL and apoB-100 VLDL assembly could be restored by removing BFA from the medium. This reactivation of VLDL assembly was accompanied by an increased removal of apoB from the microsomal membranes, but there was no detectable increase in the small quantity of VLDL apoB that was recovered from the microsomal lumen. In the absence of BFA, during pulse-chase experiments the pattern of change in the specific radioactivity of microsomal membrane apoB was similar to that of the secreted VLDL apoB whereas that of the lumenal apoB resembled that of the secreted HDL apoB. The results suggest that membrane-associated apoB is the main direct precursor of secreted VLDL apoB in primary cultures of rat hepatocytes and that VLDL assembly does not involve primarily microsomal lumenal apoB as an intermediate.

摘要

布雷菲德菌素A(BFA)以0.2微克/毫升的浓度添加到大鼠肝细胞原代培养物中,可阻止新合成的载脂蛋白B(apoB)组装成成熟的分泌性极低密度脂蛋白(VLDL),但不阻止apoB以密度更高的颗粒(高密度脂蛋白apoB)或白蛋白的形式分泌。未组装的apoB仍与细胞微粒体部分的膜相关联。BFA对这些囊泡腔内apoB的清除没有影响。VLDL apoB仅占微粒体腔内总apoB的一小部分。需要更高浓度(5微克/毫升)的BFA来阻止高密度脂蛋白apoB和白蛋白的分泌。在这些条件下,apoB在微粒体腔内以及这些囊泡的膜中积累。同样,apoB VLDL仅占腔内总apoB的一小部分。通过从培养基中去除BFA,可以恢复apoB - 48 VLDL和apoB - 100 VLDL的组装。VLDL组装的这种重新激活伴随着从微粒体膜中apoB清除的增加,但从微粒体腔内回收的少量VLDL apoB没有可检测到的增加。在没有BFA的情况下,在脉冲追踪实验中,微粒体膜apoB的比放射性变化模式与分泌的VLDL apoB相似,而腔内apoB的变化模式与分泌的高密度脂蛋白apoB相似。结果表明,膜相关的apoB是大鼠肝细胞原代培养物中分泌的VLDL apoB的主要直接前体,并且VLDL组装主要不涉及微粒体腔内apoB作为中间体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验